Becton, Dickinson and Company (BDX)
NYSE: BDX · Real-Time Price · USD
185.32
+1.69 (0.92%)
At close: Jul 25, 2025, 4:00 PM
185.35
+0.03 (0.02%)
After-hours: Jul 25, 2025, 4:59 PM EDT
BDX Revenue
Becton, Dickinson and Company had revenue of $5.27B in the quarter ending March 31, 2025, with 4.50% growth. This brings the company's revenue in the last twelve months to $20.87B, up 5.84% year-over-year. In the fiscal year ending September 30, 2024, Becton, Dickinson and Company had annual revenue of $20.18B with 4.16% growth.
Revenue (ttm)
$20.87B
Revenue Growth
+5.84%
P/S Ratio
2.54
Revenue / Employee
$285,849
Employees
73,000
Market Cap
53.11B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 20.18B | 806.00M | 4.16% |
Sep 30, 2023 | 19.37B | 502.00M | 2.66% |
Sep 30, 2022 | 18.87B | -261.00M | -1.36% |
Sep 30, 2021 | 19.13B | 3.06B | 19.02% |
Sep 30, 2020 | 16.07B | -1.22B | -7.03% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
Novartis AG | 55.19B |
AstraZeneca | 54.98B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
BDX News
- 2 days ago - BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs - PRNewsWire
- 3 days ago - BD Board Declares Dividend - PRNewsWire
- 3 days ago - Best Dividend Kings: July 2025 - Seeking Alpha
- 9 days ago - WATERS CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT - Business Wire
- 11 days ago - Becton Dickinson gets its spinoff deal, but the stock is still falling - Market Watch
- 11 days ago - Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing - PRNewsWire
- 18 days ago - BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment - PRNewsWire
- 26 days ago - Best Dividend Aristocrats For July 2025 - Seeking Alpha